Chromosomal Aberrations in Lymphocytes of Lung Cancer Patients Treated with Carbon Ions

  • LEE Ryonfa
    Heavy-Ion Radiobiology Research Group, National Institute of Radiological Sciences
  • YAMADA Shigeru
    Charged Particle Therapy Center Hospital, National Institute of Radiological Sciences
  • YAMAMOTO Naoyoshi
    Charged Particle Therapy Center Hospital, National Institute of Radiological Sciences
  • MIYAMOTO Tadaaki
    Charged Particle Therapy Center Hospital, National Institute of Radiological Sciences
  • ANDO Koichi
    Heavy-Ion Radiobiology Research Group, National Institute of Radiological Sciences
  • DURANTE Marco
    Department of Physics, University `Federico II', Monte S. Angelo
  • TSUJII Hirohiko
    Charged Particle Therapy Center Hospital, National Institute of Radiological Sciences

Search this article

Abstract

The purpose of this study is to investigate the normal tissue damage caused by carbon-ion therapy. We measured chromosomal aberrations in peripheral blood lymphocytes before, during, and after radiotherapy, using the techniques of fluorescence in situ hybridization (FISH) and chemically induced premature chromosome condensation (PCC). Twenty-two lung cancer patients treated at HIMAC (Heavy Ion Medical Accelerator in Chiba) entered the study and signed an informed consent. Frequencies of lymphocytes with chromosomal aberrations at the end of carbon-ion therapy varied among the patients. This frequency was significantly correlated to the radiation field size and weakly correlated to the counts of white blood cells and lymphocytes during the treatment. As a result, we have found that chromosomal aberrations in peripheral blood lymphocytes from patients treated for lung cancer by carbon-ions were dependent on target volume, possibly reflecting the increased involvement of lymph nodes in the target field.<br>

Journal

Citations (3)*help

See more

References(26)*help

See more

Related Projects

See more

Details 詳細情報について

Report a problem

Back to top